As on Thursday, Revelation Biosciences Inc (NASDAQ: REVB) started slowly as it slid -3.41% to $0.45, before settling in for the price of $0.47 at the close. Taking a more long-term approach, REVB posted a 52-week range of $0.42-$25.26.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that the giant of the Healthcare sector posted annual sales growth of 0.00% over the last 5 years. Nevertheless, stock’s Earnings Per Share (EPS) this year is -1311.32%. This publicly-traded company’s shares outstanding now amounts to $4.29 million, simultaneously with a float of $4.29 million. The organization now has a market capitalization sitting at $1.95 million. At the time of writing, stock’s 50-day Moving Average stood at $0.8132, while the 200-day Moving Average is $1.6489.
Revelation Biosciences Inc (REVB) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Revelation Biosciences Inc’s current insider ownership accounts for 0.08%, in contrast to 2.31% institutional ownership. According to the most recent insider trade that took place on Dec 08 ’23, this organization’s Director sold 27,771 shares at the rate of 0.52, making the entire transaction reach 14,438 in total value, affecting insider ownership by 0.
Revelation Biosciences Inc (REVB) Earnings and Revenue Records
Revelation Biosciences Inc’s EPS decrease for this current 12-month fiscal period is -1311.32% and is forecasted to reach -2.12 in the upcoming year.
Revelation Biosciences Inc (NASDAQ: REVB) Trading Performance Indicators
Let’s observe the current performance indicators for Revelation Biosciences Inc (REVB). It’s Quick Ratio in the last reported quarter now stands at 1.64. The Stock has managed to achieve an average true range (ATR) of 0.10.
In the same vein, REVB’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -16.75, a figure that is expected to reach -0.65 in the next quarter, and analysts are predicting that it will be -2.12 at the market close of one year from today.
Technical Analysis of Revelation Biosciences Inc (REVB)
Through scrutinizing the latest numbers posted by the [Revelation Biosciences Inc, REVB], it can be observed that its last 5-days Average volume of 5.79 million was better the volume of 0.96 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 5.42% While, its Average True Range was 0.1119.
Raw Stochastic average of Revelation Biosciences Inc (REVB) in the period of the previous 100 days is set at 1.10%, which indicates a major fall in contrast to 6.10% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 278.04% that was higher than 197.15% volatility it exhibited in the past 100-days period.
